PARMAX logo

Parmax Pharma Ltd

PARMAX·BSE·
132.45 +1.30 (+0.99%)
Market Cap14.16 Cr
PE Ratio
Volume12,767
Day High - Low132.45 - 132.45
52W High-Low132.45 - 22.60
DocStoX Score
1.9/10
Poor
Fair Value
Sign in to see
ROE
105.30%
Strong
P/E
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals & Biotechnology
Overall View
Mixed

Price performance

52W22.60
132.45
DocStoX take

Supported by momentum (7.5), but held back by growth (0.0). Momentum looks strong at 7.5, but that is offset by growth at 0.0 and quality at 1.8. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence
1.9
/10
Poor
Quality
Weak
ROE 105.3%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue -14.3% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
Strong
100% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹14 Cr
52W High / Low
₹132 / ₹23
Dividend Yield
0.00%
Promoter Holding
30.80%
EPS (TTM)
₹-5.59
Book Value

Key highlights

  • Strong returns on equity (105%)
  • Low leverage — D/E 0.00
  • Revenue shrinking 14% a year
  • Loss-making in some of the last 5 years
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals & Biotechnology

Parmax Pharma Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.